Research Topics
Genomes and GenesSpecies | Jeffrey AndersonSummaryAffiliation: LDS Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular diseaseJeffrey L Anderson
Cardiovascular Department, LDS Hospital, and University of Utah, Salt Lake City, Utah, USA
Am J Cardiol 99:169-74. 2007..A total CBC score is an important new addition to risk prediction, and it can be easily generated by computer for clinical use at negligible incremental cost...
Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?Jeffrey L Anderson
Cardiovascular Department, LDS Hospital, Salt Lake City, UT 84143, USA
Am Heart J 153:67-73. 2007....
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulationJeffrey L Anderson
Cardiovascular Department, LDS Hospital, Intermountain Healthcare, Salt Lake City, UT, USA
Circulation 116:2563-70. 2007..Pharmacogenetic-guided dosing of warfarin is a promising application of "personalized medicine" but has not been adequately tested in randomized trials...
Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary preventionJeffrey L Anderson
Cardiovascular Department, LDS Hospital, University of Utah, 325 8th Avenue, Salt Lake City, UT 84143, USA
Am J Cardiol 101:23F-33F. 2008..02586 mmol/L) is now recommended as a reasonable therapeutic goal...
Progress in unraveling the genetics of coronary artery disease and myocardial infarctionJeffrey L Anderson
Department of Cardiology, LDS Hospital, Salt Lake City, UT 84143, USA
Curr Atheroscler Rep 9:179-86. 2007..Despite the complexity of coronary heart disease genetics, steady progress can be expected...
Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery diseaseBryant M Whiting
Cardiovascular Department, LDS Hospital, Salt Lake City, UT 84143, USA
Am Heart J 150:243-50. 2005..Moderate-sized studies have suggested that variants of candidate genes can influence laboratory markers of coronary artery disease (CAD), but whether they predict parallel changes in clinical CAD risk is unknown...
Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetesMatthew J Kolek
Cardiovascular Department, Division of Cardiology, LDS Hospital, Salt Lake City, Utah 84143, USA
Am Heart J 148:1034-40. 2004..We evaluated whether the Asp299Gly polymorphism in the TLR4 gene, which impairs inflammatory responses, is associated with reduced vascular inflammation (assessed by C-reactive protein [CRP]) and a decreased risk for CAD and diabetes...
Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery diseaseBenjamin D Horne
Cardiovascular Department, Intermountain Medical Center, Murray, UT 84157, USA
Circ Cardiovasc Genet 1:85-92. 2008..Using angiographic coronary artery disease (CAD) phenotyping, this study evaluated whether 9p21 single-nucleotide polymorphisms predict ischemic events (eg, myocardial infarction [MI]) among CAD patients...
Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utilityJeffrey L Anderson
Cardiovascular Department, Intermountain Medical Center, Murray, UT 84107, USA
Am Heart J 156:1155-1162.e2. 2008..Variants at the 9p21 locus have been associated with coronary heart disease, but their precise disease phenotype and utility for clinical risk assessment are uncertain...
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective studyJohn F Carlquist
Department of Medicine, Division of Cardiology, University of Utah School of Medicine, Cardiovascular Department, LDS Hospital, Salt Lake City, Utah, USA
J Thromb Thrombolysis 22:191-7. 2006..vitamin K epoxide reductase complex subunit 1-VKORC1). We hypothesized that variants in these two genes explain a substantial proportion of variability in stable warfarin dose and could be used as a basis for improved dosing algorithms...
Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study)Heidi T May
Intermountain Medical Center and LDS Hospital, Salt Lake City, Utah, USA
Am J Cardiol 101:486-9. 2008..In conclusion, in this trial of mixed dyslipidemic patients with diabetes, combination therapy was more effective in changing a variety of other cardiovascular risk markers...
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery diseaseJohn F Carlquist
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
Am Heart J 146:1007-14. 2003..We studied CETP Taq1B genotype, plasma HDL, and clinical events among all patients and patients stratified by statin treatment...
The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failureMatthew J Kolek
Cardiovascular Department, LDS Hospital, Salt Lake City, UT 84143, USA
J Card Fail 11:677-83. 2005..A common variant of the adenosine monophosphate deaminase (AMPD)-1 gene (C34T) results in enzymatic inactivity and may increase adenosine in cardiac muscle and confer cardioprotection through ischemic preconditioning...
Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiographyBenjamin D Horne
Cardiovascular Department, Intermountain Medical Center, Murray, Utah, USA
Am J Cardiol 102:814-819. 2008..In conclusion, not only proscription of tobacco, but also routine periodic fasting was associated with lower risk of CAD...
Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery diseaseLillian L C Khor
Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
Am J Med 117:657-64. 2004..This sex-age interaction may have important implications for C-reactive protein-based secondary risk assessment and requires further investigation...
Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarctionJames S Zebrack
University of Utah School of Medicine, Salt Lake City, Utah 84132-2401, USA
Am J Cardiol 89:145-9. 2002....
Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association studyBenjamin D Horne
Cardiovascular Department, LDS Hospital, Intermountain Medical Center, Salt Lake City, UT 84143, USA
Am Heart J 154:969-75. 2007..In an independent but demographically similar population, this study tested 6 SNPs that were previously reported to be associated with MI...
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) studyJoseph B Muhlestein
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
J Am Coll Cardiol 48:396-401. 2006..The primary objective was to determine the effect of statin-fibrate combination therapy on inflammatory biomarkers in patients with diabetes...
Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowingKent G Meredith
Cardiovascular Department, LDS Hospital, Division of Cardiology, University of Utah, Salt Lake City, Utah, USA
Am J Cardiol 99:149-53. 2007..In conclusion, this randomized trial in patients with chronic stable coronary artery disease showed a strong dose response for simvastatin for total and low-density lipoprotein cholesterol lowering but not for hs-CRP...
Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery diseaseBenjamin D Horne
Cardiovascular Department, LDS Hospital, Intermountain Medical Center, University of Utah, Salt Lake City, Utah 84143, USA
J Am Coll Cardiol 49:2053-60. 2007....
Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery diseaseJeffrey L Anderson
Cardiovascular Department, Intermountain Medical Center, Murray, UT 84107, USA
Am Heart J 160:250-256.e3. 2010....
Exceptional mortality prediction by risk scores from common laboratory testsBenjamin D Horne
Cardiovascular Department, Intermountain Medical Center, Murray, Utah 84157, USA
Am J Med 122:550-8. 2009..Many of their components are not commonly used, but they might contain independent risk information. This study tested the ability of a risk score combining all components to predict all-cause mortality...
Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patientsAbdallah G Kfoury
Heart Failure Prevention and Treatment Program, Intermountain Medical Center and Intermountain Healthcare, 5121 S Cottonwood Street, Murray, UT 84107, USA
J Card Fail 14:95-102. 2008..Although adherence to these HF care processes may be improving, their collective impact on survival is not yet settled...
Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery diseaseBenjamin D Horne
Cardiovascular Department, LDS Hospital, Intermountain Medical Center, Salt Lake City, UT 84143, USA
Am Heart J 154:751-8. 2007..Furthermore, differentiation of predictive ability by end point (MI vs CAD) has not been addressed. This study evaluated the association with MI of SNPs in genes encoding MMPs 1, 2, 3, and 9 and TIMPs 1, 2, and 3...
Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic targetJohn F Carlquist
LDS Hospital, Cardiology Department, 8th Avenue and C Street, Salt Lake City, UT 84143, USA
Expert Rev Mol Diagn 7:511-7. 2007..Considering the large number of biomarkers currently under evaluation, it is probable that useful additions to existing risk models may be found in combinatorial models...
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiographyMatthew T Rondina
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
Cardiology 109:196-201. 2008..We evaluated sCD40L levels and future cardiovascular events in patients not experiencing ACS...
Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosingJohn F Carlquist
Department of Internal Medicine, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT, USA
J Thromb Thrombolysis 26:1-7. 2008..99. Combined with a method for rapid buccal swab DNA extraction, genotyping results were obtained in a median of 59 min. These methods should facilitate genotype-driven warfarin dosing in "real-time" clinical practice...
Inconsistencies in the genetic prediction of HDL cholesterol versus atherosclerosisJohn Carlquist
Department of Internal Medicine, Division of Cardiology, University of Utah School of Medicine, Cardiovascular Department, LDS Hospital, Intermountain Healthcare, Salt Lake City, Utah 84143, USA
Curr Opin Cardiol 22:352-8. 2007..Genetic variants within this network can increase plasma HDL, but not with uniformly beneficial clinical outcomes. The purpose of this review is to explore and propose mechanisms for these discrepant observations...
Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessmentJessica L Clarke
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
Am J Cardiol 95:155-8. 2005..This suggests that the conclusions of previous studies performed using the medium-sensitivity assay are still valid but that cross-study comparisons should use percentile rank...
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary interventionJoseph B Muhlestein
LDS Hospital, Salt Lake City, Utah 84143, USA
Am Heart J 146:351-8. 2003..Diabetes mellitus (DM) is predictive of increased mortality for patients with coronary artery disease (CAD). To what extent this risk extends below the diabetic threshold (fasting glucose level [FG] <126 mg/dL) is uncertain...
Role of inflammation in cardiovascular disease: how to use C-reactive protein in clinical practiceJames S Zebrack
University of Utah School of Medicine, Department of Internal Medicine, Division of Cardiology, Salt Lake City, UT, USA
Prog Cardiovasc Nurs 17:174-85. 2002..Finally, the authors summarize future expectations for assessing and modulating the vascular inflammation to inhibit initiation and progression of the atherosclerotic process...
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with anginaJames S Zebrack
Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
J Am Coll Cardiol 39:632-7. 2002..Severity/extent of CAD and CRP are independent and additive predictors of risk. Therapy should target CRP-associated risk as well as angiographically evident stenosis...
Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary diseaseBenjamin D Horne
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
Ann Epidemiol 14:143-50. 2004..This suggests that SES remains a significant predictor of health outcomes after CAD has developed, and that geographic measures of SES deserve further evaluation...
Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery diseaseJoseph B Muhlestein
Intermountain Medical Center, Murray, Utah University of Utah, Salt Lake City, Utah, USA
Am J Cardiol 106:764-9. 2010..In conclusion, elevated baseline PRA is associated with cardiac morbidity and mortality in patients with coronary artery disease but normal left ventricular function and no previous MI or HF...
C-reactive protein predicts death in patients with non-ischemic cardiomyopathyBrianna S Ronnow
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
Cardiology 104:196-201. 2005..0) significantly and independently predicted mortality. Even in the absence of coronary artery disease, patients with left ventricular dysfunction are at increased risk of mortality based on their baseline CRP concentrations...
A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunctionYoshikazu Yazaki
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
J Card Fail 10:316-20. 2004..This variant might lead to ischemic preconditioning by increasing tissue adenosine. We tested whether the survival benefit of C34T occurs preferentially in the setting of ischemic left ventricular dysfunction...
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary diseaseBenjamin D Horne
Cardiovascular Department, LDS Hospital, Salt Lake City, UT 84143, USA
Circulation 107:258-63. 2003..This finding supports the hypothesis that statins have beneficial, "lipid-independent," antiinflammatory effects. The mechanism of statin benefit associated with CMV seropositivity remains to be determined...
Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?Jeffrey L Anderson
Cardiovascular Department, LDS Hospital and University of Utah, Salt Lake City, Utah, USA
Cardiology 101:185-93. 2004..The prevalence of the metabolic syndrome (MS) is growing. The Adult Treatment Panel (ATP) III provided a uniform definition of MS but no information on its predictive ability...
Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control studyPaul N Hopkins
Cardiovascular Genetics Research, Department of Internal Medicine, Cardiology Division, University of Utah School of Medicine, Salt Lake City, UT 84108, USA
Atherosclerosis 207:559-66. 2009..30 with TG>150mg/dL) indicative of atherogenic remnant accumulation (type III hyperlipidemia). However, virtually no reports are available which examine potential associations between CAD and VLDL-C/TG at the lower end of the spectrum...
Which white blood cell subtypes predict increased cardiovascular risk?Benjamin D Horne
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
J Am Coll Cardiol 45:1638-43. 2005..We sought to determine the predictive ability of total white blood cell (WBC) count and its subtypes for risk of death or myocardial infarction (MI)...
Lack of association of tegaserod with adverse cardiovascular outcomes in a matched case-control studyJeffrey L Anderson
Cardiovascular Department, Intermountain Medical Center, Murray, Utah 84107, USA
J Cardiovasc Pharmacol Ther 14:170-5. 2009..This large epidemiologic study failed to confirm a reported large event differential for tegaserod that was noted incidentally in a clinical trials database, suggesting that the prior observation may have been due to chance...
Frequency of elevation of C-reactive protein in atrial fibrillationJeffrey L Anderson
Cardiovascular Department, LDS Hospital, University of Utah, Salt Lake City 84143, USA
Am J Cardiol 94:1255-9. 2004..Increased CRP is a new risk marker for AF propensity, and testing therapies that target inflammation should be considered...
Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary deathHeidi T May
Cardiovascular Department, LDS Hospital, Salt Lake City, UT 84143, USA
Am Heart J 152:997-1003. 2006..We evaluated the independent association of lipoprotein-associated phospholipase A2 (Lp-PLA2) to angiographic CAD and CV events adjusting for standard factors, lipids, and CRP...
Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patientsChloe A Allen Maycock
Cardiology Research, LDS Hospital, 8th Avenue and C Street, Salt Lake City, Utah 84143, USA
J Am Coll Cardiol 40:1777-85. 2002..Although older patients were less likely to receive statin therapy, they received a greater absolute risk reduction than younger individuals. More aggressive statin use after CAD diagnosis may be indicated, even in older patients...
Failure of benefit and early hazard of bucindolol for Class IV heart failureJeffrey L Anderson
Division of Cardiology, LDS Hospital, University of Utah, Salt Lake City 84143, USA
J Card Fail 9:266-77. 2003..CONCLUSIONS: Class IV HF patients in BEST were at high risk. Bucindolol did not reduce death or HF hospitalization and was associated with early hazard...
Cardiovascular pharmacogenomics: current status, future prospectsJeffrey L Anderson
Intermountain Heart Collaborative Research Group, LDS Hospital Cardiovascular Department, and University of Utah School of Medicine, Salt Lake City, Utah 84143, USA
J Cardiovasc Pharmacol Ther 8:71-83. 2003..Rapid research progress and initial clinical applications with pharmacogenomics are foreseen in the near future...
Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassayThomas B Martins
Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
Am J Clin Pathol 125:906-13. 2006..017), and CRP (P pound .001). Cytokine profiles may have a role in differentiating patients with CAD with MI from those with chest pain due to other disorders and in deciphering the role of inflammation in the pathogenesis of CAD...
Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery diseaseJeffrey L Anderson
Cardiovascular Department, LDS Hospital, and University of Utah School of Medicine, Salt Lake City, Utah 84143, USA
Am J Cardiol 90:536-9. 2002
High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein geneBenjamin D Horne
Cardiovascular Department, LDS Hospital, Salt Lake City, UT 84143, USA
Ann Hum Genet 70:524-34. 2006..This study provides an optimal set of tSNPs for association analyses of CETP. The observed complexity of LD structure highlights the importance of using methods, such as PCA, that allow for multiple dynamics in intragenic LD structure...
Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deploymentT Jared Bunch
Cardiovascular Department, LDS Hospital and University of Utah, Salt Lake City 84143, USA
Am J Cardiol 90:299-302. 2002
Early effects of statins in patients with coronary artery disease and high C-reactive proteinJoseph B Muhlestein
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
Am J Cardiol 94:1107-12. 2004..This provides further evidence of an anti-inflammatory effect of statins...
Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiographyTroy E Madsen
Division of Emergency Medicine, University of Utah, Salt Lake City, UT, USA
Crit Pathw Cardiol 8:167-71. 2009..The apparent inverse relation of risk with volume in the overall population is likely explained by clinical practice bias. If confirmed, these results may have important clinical implications...
Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategiesMegan B Smith
Department of Nutrition, Dietetics and Food Sciences, Utah State University, Logan, Utah, USA
Cardiology 116:61-9. 2010..Multiple factors influence warfarin metabolism and can significantly affect the risk of adverse events. The extent to which patients understand the modifiable factors that impact on warfarin safety and efficacy is unclear...
Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart RegistryTami L Bair
Cardiovascular Department, University of Utah, Salt Lake City, USA
Circulation 116:I226-31. 2007..In this study, we examined the outcomes of major adverse cardiovascular events and death for subgroups of typical "real-world" patients undergoing coronary revascularization in the modern era...
Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressureRobert Kevin Rogers
University of Utah, Salt Lake City, 84132 2401, USA
Am Heart J 158:777-83. 2009..B-type natriuretic peptide (BNP) correlates with left ventricular (LV) end-diastolic pressure (LVEDP) and predicts cardiovascular events. We sought to determine whether BNP has prognostic value independent of LVEDP...
Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary interventionBenjamin D Horne
LDS Hospital, Salt Lake City, Utah 84143, USA
Am Heart J 144:491-500. 2002..CONCLUSION: Pathogen burden was associated with clinical coronary restenosis, an association that deserves further exploration and evaluation. CRP, a marker of inflammation, was not associated with an increased risk of restenosis...
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptideHeidi T May
LDS Hospital, Intermountain Medical Center, Salt Lake City, Utah, USA
Am J Cardiol 100:697-700. 2007..02). In conclusion, the SHFM predicts survival in patients with HF in a hospital-based population, with areas under the curve similar to those from data on which models were initially fit...
The role of infection in the pathogenesis of cardiovascular diseaseJames S Zebrack
Department of Internal Medicine, Division of Cardiology, University of Utah School of Medicine, c o LDS Hospital, Eighth Avenue and C Street, Salt Lake City, UT 84143, USA
Prog Cardiovasc Nurs 18:42-9. 2003..This manuscript summarizes current understanding of the role of infectious agents as a trigger of inflammation, as a contributor to atherosclerosis, and the potential role of antibiotic therapy in the treatment of atherosclerosis...
Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication programJason M Lappe
Intermountain Health Care, LDS Hospital, Salt Lake City, Utah 84143, USA
Ann Intern Med 141:446-53. 2004..Despite recent advances in the treatment and prevention of cardiovascular disease, a treatment gap for secondary prevention medications still exists...
Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patientsJoseph B Muhlestein
Division of Cardiology, Department of Cardiovascular Medicine, LDS Hospital, Salt Lake City, Utah 84143, USA
Am Heart J 150:182-7. 2005..However, few studies have had a sufficient sample size or adequate follow-up to determine whether this advantage results in a positive effect on mortality...
Do statins increase the risk of idiopathic polyneuropathy?Jeffrey L Anderson
Cardiovascular Department, LDS Hospital, Cardiology Division, Intermountain Health Care, Salt Lake City, Utah 84143, USA
Am J Cardiol 95:1097-9. 2005..It was found that statin use before diagnosis was not significantly greater in patients than controls (odds ratio 1.30, 95% confidence interval 0.3 to 2.1, p = 0.27), nor were doses different between patients and controls...
Antibiotic trials for coronary heart diseaseJeffrey L Anderson
University of Utah School of Medicine, Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
Tex Heart Inst J 31:33-8. 2004..New and innovative experimental approaches, in addition to traditionally designed antibiotic trials, should be welcome in our attempts to gain adequate insight into the role of infection in atherosclerosis and its therapy...
The role of inflammation and infection in the pathogenesis and evolution of coronary artery diseaseJames S Zebrack
University of Utah School of Medicine, Department of Internal Medicine, Division of Cardiology, 30 North 1900 East, 4N100, Salt Lake City 84132-2401, USA
Curr Cardiol Rep 4:278-88. 2002..Whether antibiotics or vaccines will be useful in CAD prevention remains to be shown. Meanwhile, therapies with proven vascular anti-inflammatory effects (eg, diet, exercise, smoking cessation, aspirin, statins) should be optimized...
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?Jeffrey L Anderson
N Engl J Med 352:1706-9. 2005
Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failureT Jared Bunch
Mayo Clinic Foundation, Rochester, Minnesota, USA
Am J Cardiol 95:827-31. 2005..No effect was observed on longitudinal incidence of AMI or the combination of death/nonfatal MI...
Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary diseaseTroy E Madsen
Ohio State University Medical Center, Columbus, OH 43210, USA
Am J Nephrol 25:45-9. 2005..This study prospectively evaluated the predictive value of serum uric acid (SUA) levels for mortality after angiographic diagnosis of CAD...
Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or deathJianhui Zhu
Cardiovascular Research Institute of the MedStar Research Institute, Washington Hospital Center, Washington, DC 20010, USA
Am J Cardiol 89:155-8. 2002..pylori seropositivity was 1.12 (95% confidence interval 0.81 to 1.54). Our data suggest that prior infection with H. pylori is not a major factor determining either risk of CAD, AMI, or death in patients with CAD...
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion groupSidney C Smith
Circulation 110:e550-3. 2004
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprololAmy J Sehnert
CardioDx, Inc, Palo Alto, California 94303, USA
J Am Coll Cardiol 52:644-51. 2008..This study investigated the role of adrenergic receptor genetics on transplant-free survival in heart failure (HF)...
Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk: do they add up yet?Jeffrey L Anderson
J Am Coll Cardiol 41:1990-3. 2003
Restenosis after coronary intervention: narrowing C-reactive protein's prognostic potential?Jeffrey L Anderson
Am J Med 115:147-9. 2003
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise thJeffrey L Anderson
J Am Coll Cardiol 50:e1-e157. 2007
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart AssociationThomas A Pearson
Circulation 107:499-511. 2003
Should C-reactive protein be measured routinely during acute myocardial infarction?James S Zebrack
Am J Med 115:735-7. 2003
Ischemic heart disease events triggered by short-term exposure to fine particulate air pollutionC Arden Pope
Brigham Young University, Provo, UT 84602 2363, USA
Circulation 114:2443-8. 2006..These findings are inconclusive and controversial and require further study. This study evaluates the role of short-term particulate exposure in triggering acute ischemic heart disease events...
A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failureStephen B Liggett
Department of Medicine, University of Maryland, Baltimore, MD 21201, USA
Proc Natl Acad Sci U S A 103:11288-93. 2006..We conclude that beta(1)AR-389 variation alters signaling in multiple models and affects the beta-blocker therapeutic response in HF and, thus, might be used to individualize treatment of the syndrome...
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999Elliott M Antman
Circulation 110:588-636. 2004
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelinesMichael H Davidson
Preventive Cardiology Center, Pritzker School of Medicine, University of Chicago, 515 North State Street, Chicago, IL 60610, USA
Am J Cardiol 101:51F-57F. 2008..However, at this time Lp-PLA(2) cannot be recommended as a target of therapy...
Sodium channel mutations and susceptibility to heart failure and atrial fibrillationTimothy M Olson
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
JAMA 293:447-54. 2005..Recently, genetic defects in calcium and potassium regulation have been discovered in patients with DCM, implicating an alternative disease mechanism. The full spectrum of genetic defects in DCM, however, has not been established...
Research Grants
- Risk Burden of Lipoprotein Metabolic Gene HaplotypesJeffrey Anderson; Fiscal Year: 2007..We believe this thorough, novel approach will lead to a major advance in genetic CHD risk assessment, enabling the vision of gene-based medicine for CHD to be realized. ..
